{"id":"multilanguage_saving_non_english_locales_form","version":"0.1.7","comment":"","format":"CambioForm.v1","templates":[{"id":"Hereditary_Cancer_Testing_report","version":"0.1.0"}],"updated":"2021-12-17T12:13:51+01:00","authors":[{"name":"Juan Ramos","email":"juan.ramos@cambio.se","organisation":""}],"customElementLibraries":null,"elements":[{"type":"form","children":[{"type":"container","children":[{"type":"row","spanlarge":12,"spanmedium":8,"spansmall":4,"children":[{"type":"column","spanlarge":12,"spanmedium":8,"spansmall":4,"children":[{"type":"input-select","name":"age_group","options":[{"text":"≤ 45 y","value":"at0004"},{"text":"46-50 y","value":"at0005"},{"text":"≥ 51 y","value":"at0006"}],"clearable":true,"display":"dropdown"},{"type":"input-select","name":"46_50_y_with_any","options":[{"text":"Unknown or limited family history","value":"at0008"},{"text":"Multiple primary breast cancers (synchronous or metachronous)","value":"at0009"},{"text":"≥1 close blood relative with breast, ovarian, pancreatic or prostate cancer at any age","value":"at0010"}],"clearable":true,"display":"dropdown"},{"type":"input-select","name":"_51_y_with_1_close_blood","options":[{"text":"Breast cancer at age ≤50 y or male breast cancer at any age","value":"at0012"},{"text":"Ovarian cancer any age","value":"at0013"},{"text":"Pancreatic cancer any age","value":"at0014"},{"text":"Metastatic, intraductal/cribriform histology, or high- or very-high risk group","value":"at0015"}],"clearable":true,"display":"dropdown"},{"type":"input-boolean","name":"_51_y_with_3_total_diagnoses","display":"checkbox"},{"type":"input-boolean","name":"_51_y_with_2_close_blood","display":"checkbox"},{"type":"input-select","name":"any_age","options":[{"text":"To aid in systemic treatment decisions using PARP inhibitors for breast cancer in the metastatic setting","value":"at0018"},{"text":"To aid in adjuvant treatment decisions with olaparib for high-risk, HER-2 negative breast cancer","value":"at0019"},{"text":"Triple-negative breast cancer","value":"at0020"},{"text":"Lobular breast cancer with personal or family history of diffuse gastric cancer","value":"at0021"},{"text":"Male breast cancer","value":"at0022"},{"text":"≥ close blood relative with male breast cancer","value":"at0023"}],"clearable":true,"display":"dropdown"}]}]},{"type":"reset-button"},{"type":"submit-button","justify":"end"}]}]}],"description":"","name":"Multilanguage saving non english locales form","language":"en","queries":null,"guidelines":null,"actions":null,"locales":{"sv-SE":{"[name='age_group']":{"label":"Age group"},"[name='46_50_y_with_any']":{"label":"46-50 y with ANY"},"[name='_51_y_with_1_close_blood']":{"label":"≥51 y with ≥1 close blood relative with ANY"},"[name='_51_y_with_3_total_diagnoses']":{"label":"≥51 y with ≥3 total diagnoses of breast cancer in patient and/ or close blood relatives"},"[name='_51_y_with_2_close_blood']":{"label":"≥51 y with ≥2 close blood relatives with either breast or prostate cancer at any age"},"[name='any_age']":{"label":"Any age"}},"sq":{"[name='age_group']":{"label":"Age group"},"[name='46_50_y_with_any']":{"label":"46-50 y with ANY"},"[name='_51_y_with_1_close_blood']":{"label":"≥51 y with ≥1 close blood relative with ANY"},"[name='_51_y_with_3_total_diagnoses']":{"label":"≥51 y with ≥3 total diagnoses of breast cancer in patient and/ or close blood relatives"},"[name='_51_y_with_2_close_blood']":{"label":"≥51 y with ≥2 close blood relatives with either breast or prostate cancer at any age"},"[name='any_age']":{"label":"Any age"}}}}